NovaSight and Tobii Demonstrate Solution for Treating Amblyopia — the Leading Cause of Vision Loss in Children

CES 2020 – NovaSight, a leading provider of digital healthcare platforms, and Tobii, the world-leader in eye tracking technology, are demonstrating NovaSight’s prototype for vision care at CES this week. The revolutionary solution combines advanced eye tracking and sophisticated artificial intelligence to treat amblyopia, a vision disorder commonly known as lazy eye, which is the leading cause of vision loss in children. “One extraordinary aspect of Tobii’s eye tracking technology is that it serves as an engine for innovation in healthcare and other kinds of specialized applications,”